🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSELECT trial: 20% MACE reduction — 6 month update Page 3

SELECT trial: 20% MACE reduction — 6 month update

Admin Tue, Sep 24, 2024 at 8:21 AM 11 replies 1,765 viewsPage 3 of 3
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
Sep 24, 2024 at 12:36 PM#11

DataDave — wow. I've been looking for this exact info for weeks.

21 7Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 18 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Sep 24, 2024 at 12:53 PM#12

Slightly tangential to SELECT trial 20% MACE but Admin reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Sep 24, 2024 at 2:53 PM
22 15PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 19 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Sep 24, 2024 at 1:10 PM#13

Thanks for sharing this, Admin. A few questions about your SELECT trial 20% experience:

  1. What dose worked best for you?
  2. How long before you noticed appetite suppression kicking in?
  3. Did your endo have any specific recommendations about SELECT trial?

I am in a similar boat and trying to learn from others' experiences before my next appointment.

30 23TomTeleRx, DoseLogDan, SleepFixSam and 27 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Sep 24, 2024 at 1:27 PM#14

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on SELECT trial 20% MACE.

To answer Dr.MetabolicMD: I get my labs done through Quest every 3 months.

Quick update: my latest labs came back even better. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

31 17BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 28 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Sep 24, 2024 at 1:44 PM#15

Relevant to SELECT trial 20% MACE — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 203 → 103 mg/dL, hsCRP 6.0 → 0.9 mg/L. All on tirzepatide for 7 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

27 11EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 24 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register